JDD Review Examines Malassezia Folliculitis and Diagnostic Challenges for Clinicians This is a must-read article from JDD. A narrative review in the Journal of Drugs in Dermatology summarizes current evidence…
Read More
Curated by the JDD Editors Missed any of our June highlights? June is our Acne and Rosacea issue and is packed with intriguing articles, and you’ll want to start to…
Read More
JDD Review: Botulinum Toxin A Shows Potential for Acne Vulgaris and Acne Scarring You don’t want to miss this article in the JDD. A systematic review in the Journal of…
Read More
Beyond the Surface: Evolving Standards in Acne Management June marks Acne Awareness Month, serving as a critical pivot point to reframe acne vulgaris not as a temporary phase, but as…
Read More
Early clinical mapping of exosome therapies in dermatology points to promise and questions Have you seen this JDD article on exosome-based dermatologic therapies? A scoping review summarized human clinical work…
Read More
A practical, consensus driven algorithm to help clinicians combine topical care and device therapies We wanted to share this February 2026 article that has been gaining a lot of attention.…
Read More
Barrier boost for acne care: A new gel moisturizer soothes, strengthens and lifts quality of life We’re highlighting a December 2025 article that features one of JDD’s most sought-after topics:…
Read More
Isotretinoin and IBD — large real‑world data offer reassurance In one of our recent JDD articles, a retrospective cohort using the TriNetX network compared acne patients exposed to long‑term, low‑dose…
Read More
From the Vault: Novel Strategy for Strengthening Dermatoporotic Skin by Managing Cellular Senescence
Microdosed Actives Target Dermal Senescence - A Surprising Lab Advance That Could Reshape Dermatoporosis Care Dermatoporosis —age‑related thinning and fragility of the skin driven by fibroblast dysfunction, ECM breakdown, and…
Read More
Clascoterone Keeps Gaining Ground in Acne Two identical Phase 3 trials (plus a long‑term extension) randomized patients ≥12 years with moderate‑to‑severe acne to twice‑daily clascoterone 1% cream or vehicle for…
Read More
Did You Miss These? Must-Listen JDD Podcasts on Acne, Dyspigmentation & Oncodermatology! Dermatology is always evolving, and if you haven’t caught the latest 'Ask the Investigator' podcast episodes, you’re missing…
Read More
Elevate your practice with the very latest clinical insights, case studies, and CME, all in one place. Discover the Acne Resource Center - your new go-to microsite for the very…
Read More
